Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (251-260 of 358) with videos related to

Pageof 36
Sort By:
Chemmedchem|March 5, 2011
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activitySergio Valente, Maria Tardugno, Mariarosaria Conte, et al.
Future Medicinal Chemistry|August 25, 2016
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studiesMargherita Brindisi, Caterina Cavella, Simone Brogi, et al.
Journal of Medicinal Chemistry|August 31, 2012
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cellsDante Rotili, Domenico Tarantino, Vincenzo Carafa, et al.
Frontiers in Nutrition|August 23, 2021
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?Liliana Montella, Federica Sarno, Lucia Altucci, et al.
European Journal of Heart Failure|January 14, 2025
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysisRosaria Benedetti, Ugo Chianese, Chiara Papulino, et al.
Nature Medicine|November 20, 2024
Editorial Expression of Concern: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cellsAngela Nebbioso, Nicole Clarke, Emilie Voltz, et al.
Nature Medicine|December 28, 2004
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cellsAngela Nebbioso, Nicole Clarke, Emilie Voltz, et al.
Blood|August 28, 2012
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemiaSadia Saeed, Colin Logie, Kees-Jan Francoijs, et al.
Chemmedchem|March 26, 2013
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Maria Tardugno, et al.
Science Advances|February 13, 2026
Accessory microRNA byproducts expand RNA interference via microprocessor-mediated cleavage activationDebora Mazzetti, Michal O Nowicki, Himanshu Soni, et al.
Pageof 36

Showing results (251-260 of 358) with videos related to

Sort By:
Pageof 36
Chemmedchem|March 5, 2011
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activitySergio Valente, Maria Tardugno, Mariarosaria Conte, et al.
Future Medicinal Chemistry|August 25, 2016
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studiesMargherita Brindisi, Caterina Cavella, Simone Brogi, et al.
Journal of Medicinal Chemistry|August 31, 2012
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cellsDante Rotili, Domenico Tarantino, Vincenzo Carafa, et al.
Frontiers in Nutrition|August 23, 2021
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?Liliana Montella, Federica Sarno, Lucia Altucci, et al.
European Journal of Heart Failure|January 14, 2025
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysisRosaria Benedetti, Ugo Chianese, Chiara Papulino, et al.
Nature Medicine|November 20, 2024
Editorial Expression of Concern: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cellsAngela Nebbioso, Nicole Clarke, Emilie Voltz, et al.
Nature Medicine|December 28, 2004
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cellsAngela Nebbioso, Nicole Clarke, Emilie Voltz, et al.
Blood|August 28, 2012
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemiaSadia Saeed, Colin Logie, Kees-Jan Francoijs, et al.
Chemmedchem|March 26, 2013
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Maria Tardugno, et al.
Science Advances|February 13, 2026
Accessory microRNA byproducts expand RNA interference via microprocessor-mediated cleavage activationDebora Mazzetti, Michal O Nowicki, Himanshu Soni, et al.
Pageof 36